123 related articles for article (PubMed ID: 1655092)
1. The platelet activating factor receptor antagonist WEB 2170 improves glomerular hemodynamics and morphology in a proliferative model of mesangial cell injury.
Stahl RA; Thaiss F; Oberle G; Brecht HM; Schoeppe W; Wenzel U; Helmchen UM
J Am Soc Nephrol; 1991 Jul; 2(1):37-44. PubMed ID: 1655092
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated mesangial cell injury--biosynthesis and function of prostanoids.
Stahl RA; Thaiss F; Kahf S; Schoeppe W; Helmchen UM
Kidney Int; 1990 Aug; 38(2):273-81. PubMed ID: 2119468
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis.
Yoo J; Schlondorff D; Neugarten J
J Pharmacol Exp Ther; 1991 Mar; 256(3):841-4. PubMed ID: 2005583
[TBL] [Abstract][Full Text] [Related]
4. Mesangial cell immune injury: effects of thromboxane receptor antagonism.
Bresnahan BA; Roman RJ; Bagchus WM; Lianos EA
J Am Soc Nephrol; 1991 Feb; 1(8):1041-7. PubMed ID: 1832980
[TBL] [Abstract][Full Text] [Related]
5. Morphologic and functional consequences of immune-mediated mesangiolysis: development of chronic glomerular sclerosis.
Stahl RA; Thaiss F; Wenzel U; Helmchen U
J Am Soc Nephrol; 1992 Apr; 2(10 Suppl):S144-8. PubMed ID: 1600130
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.
Thaiss F; Mihatsch MJ; Oberle G; Haberstroh U; Brecht HM; Stahl RA
J Lab Clin Med; 1994 Dec; 124(6):775-81. PubMed ID: 7798789
[TBL] [Abstract][Full Text] [Related]
7. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
de la Cruz JP; Moreno A; Ruiz-Ruiz MI; García-Campos J; Sánchez de la Cuesta F
Eur J Pharmacol; 1998 Oct; 360(1):37-42. PubMed ID: 9845270
[TBL] [Abstract][Full Text] [Related]
8. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
10. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
Lianos EA; Andres GA; Dunn MJ
J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
[TBL] [Abstract][Full Text] [Related]
11. Glomerular effects of cholera toxin in isolated perfused rat kidney: a potential role for platelet activating factor.
Monteiro HS; Lima AA; Fonteles MC
Pharmacol Toxicol; 1999 Sep; 85(3):105-10. PubMed ID: 10522748
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of habu venom-induced glomerular lesions: potential role for platelet secretory proteins.
Barnes JL
J Lab Clin Med; 1989 Aug; 114(2):200-6. PubMed ID: 2754307
[TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis.
Bertani T; Livio M; Macconi D; Morigi M; Bisogno G; Patrono C; Remuzzi G
Kidney Int; 1987 Jun; 31(6):1248-56. PubMed ID: 3039232
[TBL] [Abstract][Full Text] [Related]
14. cAMP mediates homologous downregulation of PAF receptor mRNA expression in mesangial cells.
Nakao A; Watanabe T; Bitoh H; Imaki H; Suzuki T; Asano K; Taniguchi S; Nosaka K; Shimizu T; Kurokawa K
Am J Physiol; 1997 Sep; 273(3 Pt 2):F445-50. PubMed ID: 9321918
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of glomerular injury in experimental immune nephritis. II. Effect of a platelet activating factor receptor antagonist in an autologous nephritis model.
Hruby ZW; Lowry RP; Forbes RD; Blais D
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):575-86. PubMed ID: 1668710
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of the mesangial phenotype in a proliferative glomerulonephritis of the rat.
Harendza S; Behrens U; Zahner G; Schneider A; Stahl RA
Nephrol Dial Transplant; 1997 Dec; 12(12):2537-41. PubMed ID: 9430848
[TBL] [Abstract][Full Text] [Related]
17. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis.
Livio M; Macconi D; Morigi M; Orisio S; Benigni A; Patrono C; Remuzzi G
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():828-32. PubMed ID: 2823570
[No Abstract] [Full Text] [Related]
18. [Effects of reactive oxygen species scavenger and platelet activating factor receptor antagonist on accelerated nephrotoxic nephritis].
Kakuta S
Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):115-24. PubMed ID: 8315875
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor mediates monocyte chemoattractant protein-1 expression in glomerular immune injury.
Jocks T; Freudenberg J; Zahner G; Stahl RA
Nephrol Dial Transplant; 1998 Jan; 13(1):37-43. PubMed ID: 9481713
[TBL] [Abstract][Full Text] [Related]
20. Immune complex effects on glomerular eicosanoid production and renal hemodynamics.
Rahman MA; Emancipator SN; Dunn MJ
Kidney Int; 1987 Jun; 31(6):1317-26. PubMed ID: 2441106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
